MOTS-C (Coming Soon) Researched for its role in mitochondrial regulation and metabolic efficiency
What this regulatory shift may enable is a more structured environment for clinical research
During host cell infection, CoVs trigger an imbalance involving increased ROS production and reduced antioxidant host responses, thereby leading to increased redox stress, reduced antiviral host responses, and increased virus-induced inflammation and apoptosis, ultimately causing cell and tissue damage and end-organ disease 3
Although research is ongoing, diseases linked to inflammation and oxidative stress, such as ulcerative colitis, may improve with glutathione IV therapy
A classic pharmacokinetic study in the Annals of Internal Medicine (Levine et al., 2004) found that a modeled 50 g IV dose produced peak plasma levels around 13,400 mol/L, versus 220 mol/L for the maximum tolerated oral regimen roughly 3070 times higher plasma concentrations with IV administration